Perk Labs - PKLBF STOCK NEWS

Perk Labs Inc. (CSE:PERK, OTC PINK:PKLBF, FKT:PKLB) has provided a corporate update on its financial statements, product development, and market strategy. Key highlights include:

1. Financial statements expected to be released in September, potentially lifting the cease trade order.
2. Subsidiary Getit Technologies has integrated U.S. tax and currency support.
3. Launch of first fully native app with white-label loyalty program.
4. Refined focus on 'Complex Purchase Environments' like stadiums, campuses, and hotels.
5. Partnership with Carleton University Students' Association for a custom-branded payment platform.

The company aims to address challenges in diverse transaction environments across multiple POS systems, offering a seamless ordering and payment experience.

Perk Labs Inc. (CSE:PERK) (OTCPINK:PKLBF) has received a failure to file cease trade order (FFCTO) from the British Columbia Securities Commission due to delays in filing its audited annual financial statements for the fiscal year ended November 30, 2023. The Canadian Securities Exchange has suspended trading of the company's securities as a result. The delay is attributed to complexities from a 2023 merger and resource constraints. Perk Labs assures that the audit is in progress and filings will be completed as soon as possible. Despite the FFCTO, the company continues to operate normally and is focusing on expanding its services to meet client demand. CEO Ryan Hardy expressed commitment to resolving regulatory delays and pursuing the company's growth strategy.

Perk Labs Inc. (CSE:PERK, OTC PINK:PKLBF, FKT:PKLB) has announced an update regarding the management cease trade order (MCTO) issued by the British Columbia Securities Commission on April 3, 2024. The MCTO, which restricts trading by the company's CEO and CFO, has been extended to July 4, 2024, due to delays in preparing audited financial statements for the fiscal year ending November 30, 2023. The MCTO does not impact other shareholders' ability to trade the company's securities. Perk Labs continues to work towards completing the filings and remains compliant with alternative information guidelines.

Perk Labs announces new non-brokered private placements aiming to raise up to $2.5 million. The company will offer 115,384,615 units at $0.013 per unit, totaling up to $1.5 million. Each unit includes one common share and one purchase warrant to buy an additional share at $0.05 within 24 months. Additionally, Perk Labs proposes a private placement of convertible debentures for up to $1 million, with a 15% interest rate and a 2-year term, convertible into common shares at $0.05 each. The placements are expected to close by June 29, 2024, pending customary conditions and approvals. Proceeds will fund sales, marketing, and working capital. Related parties may participate, and securities will be subject to a statutory hold period of four months plus one day.

Perk Labs has updated the status of its Management Cease Trade Order (MCTO) granted by the British Columbia Securities Commission on April 3, 2024. The company has applied for an extension due to delays in preparing audited financial statements for the year ending November 30, 2023. This affects the CEO and CFO's trading abilities but not other shareholders. Since the last announcement, there have been no material changes or failures in fulfilling obligations. Perk Labs will continue issuing bi-weekly updates until compliance is achieved.

Perk Labs Inc. provided an update on the status of a management cease trade order (MCTO) application to the British Columbia Securities Commission. The Company was granted a voluntary MCTO to file its audited annual financial statements and related management's discussion and analysis. The MCTO prohibits trading by the CEO and CFO but not other shareholders. The Company aims to complete the filings by May 31, 2024, and will issue bi-weekly default status reports until then.

Perk Labs Inc. announces an agreement with Gibson & Associates for a custom payment portal. Gibson & Associates has chosen Perk's subsidiary, Getit Technologies Inc., as its payment technology provider. The custom-branded payment portal offers convenient online payments through a button embedded in Gibson & Associates' website. Getit's technology allows for quick credit card processing and recurring billing options, catering to the needs of Gibson & Associates' clients.

Perk Labs Inc. announced the successful closing of non-brokered private placements, raising CAD $789,000 through the issuance of 78,900,000 units at $0.01 per unit and $25,000 through convertible debentures. The units consist of common shares and warrants, while the debentures mature in two years with a 15% annual interest rate. The proceeds will be utilized for general working capital, accounts payable, and employee salaries. A related party acquired $73,000 worth of units in the private placement.

Perk Labs Inc. provided an update on the status of a management cease trade order (MCTO) granted by the British Columbia Securities Commission. The MCTO was issued to allow additional time for the company to file its audited annual financial statements by May 31, 2024. The order prohibits trading by the CEO and CFO but does not affect other shareholders. The company is working diligently to complete the filings and will issue bi-weekly default status reports until the requirements are met.